Table 4.
Funder | n | % of total | Mean % PPI (95% CI) |
NIHR | 320 | 10.7 | 57.2 (51.8 to 62.6) |
CIHR | 90 | 3.0 | 41.1 (30.9 to 51.3) |
ZonMw | 25 | 0.8 | 40.0 (20.4 to 59.6) |
MRC | 58 | 1.9 | 39.7 (27.0 to 52.4) |
ESRC | 41 | 1.4 | 29.3 (15.2 to 43.4) |
Wellcome Trust | 103 | 3.4 | 28.2 (19.4 to 36.9) |
NHMRC | 111 | 3.7 | 27.9 (19.5 to 36.3) |
NIH | 81 | 2.7 | 27.2 (17.4 to 36.9) |
EU | 69 | 2.3 | 23.2 (13.2 to 33.2) |
Carlos III | 30 | 1.0 | 13.3 (1.0 to 25.7) |
Gates Foundation | 33 | 1.1 | 12.1 (0.8 to 23.4) |
Chinese | 178 | 5.9 | 3.4 (0.7 to 6.0) |
Carlos III, Instituto de Salud Carlos III (Spain); Chinese, Key Research or other Chinese state funder, for example, National Science Foundation of China; CIHR, Canadian Institutes of Health Research; ESRC, Economic and Social Research Council (UK); EU, European Union funding; Gates, The Bill and Melinda Gates Foundation (USA); MRC, Medical Research Council (UK); NHMRC, National Health and Medical Research Council (Australia); NIH, US National Institutes of Health; NIHR, National Institute of Health Research (UK); PPI, patient and public involvement; Wellcome, The Wellcome Trust (UK); ZonMw, The Netherlands Organisation for Health Research and Development.